Published in Blood on October 01, 2002
P2 receptors: intracellular signaling. Pflugers Arch (2006) 1.48
Regulation and functional consequences of ADP receptor-mediated ERK2 activation in platelets. Biochem J (2007) 1.23
The P2X1 receptor and platelet function. Purinergic Signal (2011) 0.89
Endosome-mediated retrograde axonal transport of P2X3 receptor signals in primary sensory neurons. Cell Res (2011) 0.86
Chlorin e6 Prevents ADP-Induced Platelet Aggregation by Decreasing PI3K-Akt Phosphorylation and Promoting cAMP Production. Evid Based Complement Alternat Med (2013) 0.79
Dual-specificity phosphatase 3 deficiency or inhibition limits platelet activation and arterial thrombosis. Circulation (2014) 0.79
Purinergic control of inflammation and thrombosis: Role of P2X1 receptors. Comput Struct Biotechnol J (2014) 0.76
Molecular and functional characterization of the human platelet Na(+) /Ca(2+) exchangers. Br J Pharmacol (2012) 0.76
Historical perspective on ADP-induced platelet activation. Purinergic Signal (2011) 0.75
Ginsenoside Rg3-enriched red ginseng extract inhibits platelet activation and in vivo thrombus formation. J Ginseng Res (2017) 0.75
The uremic retention solute p-cresyl sulfate and markers of endothelial damage. Am J Kidney Dis (2009) 2.34
A functional genomics approach reveals novel quantitative trait loci associated with platelet signaling pathways. Blood (2009) 2.25
Diesel exhaust particles in lung acutely enhance experimental peripheral thrombosis. Circulation (2003) 2.12
Ultrafine particles affect experimental thrombosis in an in vivo hamster model. Am J Respir Crit Care Med (2002) 2.06
Novel inhibitors of alkaline phosphatase suppress vascular smooth muscle cell calcification. J Bone Miner Res (2007) 1.92
Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes. Blood (2007) 1.86
Possible mechanisms of the cardiovascular effects of inhaled particles: systemic translocation and prothrombotic effects. Toxicol Lett (2004) 1.70
Pharmacological inhibition of PHOSPHO1 suppresses vascular smooth muscle cell calcification. J Bone Miner Res (2013) 1.60
Response variability to aspirin as assessed by the platelet function analyzer (PFA)-100. A systematic review. Thromb Haemost (2008) 1.60
The Belgian Improvement Study on Oral Anticoagulation Therapy: a randomized clinical trial. Eur Heart J (2005) 1.58
Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy. J Clin Invest (2005) 1.55
Progression of the prothrombotic state in aging Bmal1-deficient mice. Arterioscler Thromb Vasc Biol (2011) 1.43
Elevated skeletal osteopontin levels contribute to the hypophosphatasia phenotype in Akp2(-/-) mice. J Bone Miner Res (2006) 1.39
Residues determining the binding specificity of uncompetitive inhibitors to tissue-nonspecific alkaline phosphatase. J Bone Miner Res (2004) 1.36
Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13. Blood (2005) 1.35
Endothelial von Willebrand factor recruits platelets to atherosclerosis-prone sites in response to hypercholesterolemia. Blood (2002) 1.33
Acute toxicity and prothrombotic effects of quantum dots: impact of surface charge. Environ Health Perspect (2008) 1.32
Size effect of intratracheally instilled particles on pulmonary inflammation and vascular thrombosis. Toxicol Appl Pharmacol (2003) 1.30
Pulmonary inflammation and thrombogenicity caused by diesel particles in hamsters: role of histamine. Am J Respir Crit Care Med (2003) 1.29
Kinetic analysis of substrate utilization by native and TNAP-, NPP1-, or PHOSPHO1-deficient matrix vesicles. J Bone Miner Res (2010) 1.29
Pharmacological stabilization of mast cells abrogates late thrombotic events induced by diesel exhaust particles in hamsters. Circulation (2004) 1.25
Overexpression of the platelet P2X1 ion channel in transgenic mice generates a novel prothrombotic phenotype. Blood (2003) 1.21
Platelet JNK1 is involved in secretion and thrombus formation. Blood (2010) 1.20
Kinetic characterization of hypophosphatasia mutations with physiological substrates. J Bone Miner Res (2002) 1.19
Effects of particulate air pollution on hemostasis. Clin Occup Environ Med (2006) 1.14
A novel mechanism of sustained platelet αIIbβ3 activation via PEAR1. Blood (2012) 1.12
Functional polymorphisms in the paternally expressed XLalphas and its cofactor ALEX decrease their mutual interaction and enhance receptor-mediated cAMP formation. Hum Mol Genet (2003) 1.12
Involvement of the mitogen-activated protein kinase c-Jun NH2-terminal kinase 1 in thrombus formation. J Biol Chem (2007) 1.12
Air pollution related prothrombotic changes in persons with diabetes. Environ Health Perspect (2010) 1.11
A novel phosphatase upregulated in Akp3 knockout mice. Am J Physiol Gastrointest Liver Physiol (2007) 1.09
Thrombospondin-1 deficiency accelerates atherosclerotic plaque maturation in ApoE-/- mice. Circ Res (2008) 1.08
The TUBB1 Q43P functional polymorphism reduces the risk of cardiovascular disease in men by modulating platelet function and structure. Blood (2005) 1.08
Lack of plasminogen activator inhibitor-1 promotes growth and abnormal matrix remodeling of advanced atherosclerotic plaques in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2002) 1.05
Thrombogenicity of beta 2-glycoprotein I-dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster. Blood (2002) 1.03
Different substitutions at residue D218 of the X-linked transcription factor GATA1 lead to altered clinical severity of macrothrombocytopenia and anemia and are associated with variable skewed X inactivation. Hum Mol Genet (2002) 1.03
Function assignment to conserved residues in mammalian alkaline phosphatases. J Biol Chem (2002) 1.00
The pituitary adenylate cyclase-activating polypeptide is a physiological inhibitor of platelet activation. J Clin Invest (2004) 0.99
Proteoliposomes harboring alkaline phosphatase and nucleotide pyrophosphatase as matrix vesicle biomimetics. J Biol Chem (2010) 0.96
-391 C to G substitution in the regulator of G-protein signalling-2 promoter increases susceptibility to the metabolic syndrome in white European men: consistency between molecular and epidemiological studies. J Hypertens (2007) 0.96
Differential Involvement of ERK2 and p38 in platelet adhesion to collagen. J Biol Chem (2005) 0.95
Activation of alphaIIbbeta3 is a sufficient but also an imperative prerequisite for activation of alpha2beta1 on platelets. Blood (2006) 0.95
Thrombospondin-1 activates medial smooth muscle cells and triggers neointima formation upon mouse carotid artery ligation. Arterioscler Thromb Vasc Biol (2007) 0.95
Impact of clock gene Bmal1 deficiency on nutritionally induced obesity in mice. Obesity (Silver Spring) (2010) 0.95
Platelets, thrombospondin-1 and human dermal fibroblasts cooperate for stimulation of endothelial cell tubulogenesis through VEGF and PAI-1 regulation. Exp Cell Res (2006) 0.94
Silica particles enhance peripheral thrombosis: key role of lung macrophage-neutrophil cross-talk. Am J Respir Crit Care Med (2005) 0.93
Fibrin formation by staphylothrombin facilitates Staphylococcus aureus-induced platelet aggregation. Thromb Haemost (2012) 0.92
The role of staphylothrombin-mediated fibrin deposition in catheter-related Staphylococcus aureus infections. J Infect Dis (2013) 0.92
P2X1-mediated ERK2 activation amplifies the collagen-induced platelet secretion by enhancing myosin light chain kinase activation. J Biol Chem (2003) 0.92
Thrombotic risk assessment in the antiphospholipid syndrome requires more than the quantification of lupus anticoagulants. Blood (2009) 0.91
Monoclonal antibody IAC-1 is specific for activated alpha2beta1 and binds to amino acids 199 to 201 of the integrin alpha2 I-domain. Blood (2004) 0.91
PACAP and its receptor VPAC1 regulate megakaryocyte maturation: therapeutic implications. Blood (2007) 0.90
PEAR1 attenuates megakaryopoiesis via control of the PI3K/PTEN pathway. Blood (2013) 0.90
Molecular cloning and characterization of the GATA1 cofactor human FOG1 and assessment of its binding to GATA1 proteins carrying D218 substitutions. Hum Genet (2002) 0.90
Pathophysiological role of vascular smooth muscle alkaline phosphatase in medial artery calcification. J Bone Miner Res (2015) 0.90
Pseudohypoparathyroidism type Ib with disturbed imprinting in the GNAS1 cluster and Gsalpha deficiency in platelets. Hum Mol Genet (2002) 0.89
Gallic acid antagonizes P-selectin-mediated platelet-leukocyte interactions: implications for the French paradox. Circulation (2005) 0.88
ATP augments von Willebrand factor-dependent shear-induced platelet aggregation through Ca2+-calmodulin and myosin light chain kinase activation. J Biol Chem (2004) 0.87
Hemostasis and inflammation: two of a kind? Thromb J (2009) 0.87
Challenges in the diagnosis of the antiphospholipid syndrome. Clin Chem (2010) 0.87
Specific inhibition of P-selectin-mediated cell adhesion by phage display-derived peptide antagonists. Blood (2002) 0.86
Laboratory diagnosis of the antiphospholipid syndrome: a plethora of obstacles to overcome. Eur J Haematol (2009) 0.86
Air pollution-associated procoagulant changes: the role of circulating microvesicles. J Thromb Haemost (2012) 0.86
Traffic air pollution and oxidized LDL. PLoS One (2011) 0.85
Short-term effect of infliximab is reflected in the clot lysis profile of patients with inflammatory bowel disease: a prospective study. Inflamm Bowel Dis (2015) 0.84
Ablation of osteopontin improves the skeletal phenotype of phospho1(-/-) mice. J Bone Miner Res (2014) 0.84
Platelet receptors. Handb Exp Pharmacol (2012) 0.83
Rational optimization of a short human P-selectin-binding peptide leads to nanomolar affinity antagonists. J Biol Chem (2003) 0.83
Effect of premature aging on murine adipose tissue. Exp Gerontol (2012) 0.82
Increased Gs signalling in platelets and impaired collagen activation, due to a defect in the dystrophin gene, result in increased blood loss during spinal surgery. Hum Mol Genet (2007) 0.81
Effect of ageing on the murine venous circulation. Histochem Cell Biol (2012) 0.81
Obesity promotes injury induced femoral artery thrombosis in mice. Thromb Res (2008) 0.81
Inverse correlation between coronary blood flow velocity and sICAM-1 level observed in ischemic heart disease patients. Atherosclerosis (2005) 0.81
Age-associated adaptations in murine adipose tissues. Endocr J (2010) 0.81
The intracellular tyrosine residues of the ATP-gated P2X(1) ion channel are essential for its function. FEBS Lett (2002) 0.80
Dabigatran inhibits Staphylococcus aureus coagulase activity. J Clin Microbiol (2010) 0.80
Short-term ethinyl estradiol treatment suppresses inferior caval vein thrombosis in obese mice. Thromb Haemost (2009) 0.80
Laboratory detection of the antiphospholipid syndrome via calibrated automated thrombography. Thromb Haemost (2009) 0.80
The P2X1 ion channel in platelet function. Platelets (2010) 0.79
Hemostatic effects of recombinant DisBa-01, a disintegrin from Bothrops alternatus. Front Biosci (2008) 0.79
Does rosiglitazone affect adiposity and cardiac function in genetic diabetic mice? Eur J Pharmacol (2012) 0.79
Thrombogenic changes in young and old mice upon subchronic exposure to air pollution in an urban roadside tunnel. Thromb Haemost (2012) 0.79